查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1971578

不孕症治療服務市場：按治療類型、不孕症類型、支付方式、治療階段、年齡層和最終用戶分類 - 全球預測 2026-2032 年

Fertility Services Market by Procedure Type, Infertility Type, Payment Type, Treatment Stage, Age Group, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，生育治療服務市場價值將達到 514.4 億美元，到 2026 年將成長至 556.4 億美元，到 2032 年將達到 900.7 億美元，複合年成長率為 8.33%。

主要市場統計數據
基準年 2025 514.4億美元
預計年份：2026年 556.4億美元
預測年份 2032 900.7億美元
複合年成長率 (%) 8.33%

權威概述了新的臨床創新、患者期望、供應鏈壓力以及重塑醫療保健機構生育服務提供的策略需求。

生育服務領域正處於快速臨床創新、人口結構變化以及支付方和監管動態演變的交匯點。臨床實務正超越傳統的體外受精（IVF）框架，而冷凍保存策略和輔助技術正在重塑醫療服務的提供方式。同時，隨著患者對便利性、透明度和結果的期望日益提高，診所和診斷檢查室被迫改善通訊協定、加大數位化投入並採用實證品質指標。

對臨床創新、數位轉型、人口結構變化和政策趨勢如何重塑生育治療服務生態系統進行前瞻性、綜合分析。

科技創新和服務模式正在推動不孕症治療各階段的變革。從慢速冷凍到玻璃化冷凍，冷凍保存技術的進步提高了胚胎和配子的存活率，使診所能夠制定多樣化的治療方案。同時，傳統體外受精（IVF）通訊協定的改進和微刺激IVF技術的出現，使臨床醫生能夠根據患者的年齡和不孕症狀調整促排卵強度，從而最佳化治療安全性和療效。

2025 年實施的貿易政策轉變和關稅措施對所有生育治療服務管道的採購韌性、臨床運作和病患支付能力的影響。

2025年實施的關稅及相關貿易措施為採購、臨床營運和病患支付能力等各領域帶來了新的、多元化的壓力。對進口實驗室設備、特殊耗材和低溫保存組件的限制，提高了採購風險的可見度，迫使許多醫療機構和診斷檢查室重新評估其供應商策略。因此，一些機構正在加快對替代供應商的認證，加強庫存緩衝，並探索與本地製造夥伴關係，以保護關鍵臨床工作流程免受供應鏈中斷的影響。

基於深度細分的洞察突顯了治療選擇、醫療保健環境、不孕症病因、支付機制、治療順序和年齡層如何影響臨床路徑和服務設計。

了解不孕症治療全程的服務需求、臨床應用和收入模式，關鍵在於掌握各個細分領域的動態變化。治療層面的差異顯著：冷凍保存策略分為慢速冷凍和玻璃化冷凍，其中玻璃化冷凍因其快速冷卻和更高的胚胎存活率而日益受到青睞。同時，傳統體外受精（IVF）和微創IVF在促排卵強度和患者耐受性方面有明顯的臨床權衡。卵胞漿內單一精子注射（ICSI）、子宮內人工授精（IUI）和促排卵在通訊協定選擇中繼續發揮不同的作用，其選擇取決於不孕症的根本類型（複雜因素、女性因素、男性因素、不明原因不孕等）和患者的年齡。

區域趨勢和跨境醫療保健的考慮因素正在推動全球生育市場在技術採用、監管合規、支付方互動和患者流動性方面的差異。

區域趨勢對醫療服務取得模式、定價架構以及病患和服務跨境流動有顯著影響。在美洲，醫療服務提供模式多種多樣，從私人資助的診所網路到影響支付方談判和服務商品搭售的公共項目，不一而足。在這些市場中，明確的監管政策和完善的報銷機制促進了先進實驗室技術的應用，而自費患者對價格的高度敏感則推動了對低強度刺激通訊協定和替代治療順序的需求。

以產品品質、垂直整合、供應鏈韌性與臨床教育為手段，實現差異化與市場進入的競爭與合作型企業策略。

在生育生態系統的競爭格局中，那些兼具卓越臨床水準、規模優勢和一體化服務模式的機構更具優勢。生殖技術和耗材製造商正加大對產品品質、監管支援和培訓計畫的投入，以促進診所採用先進的診療通訊協定。診斷服務提供者則透過檢測準確性、快速出結果以及支持胚胎選擇和男性因素評估的綜合報告來提升自身競爭力。同時，診所集團和醫院系統正在探索垂直整合策略，將檢測服務納入內部，以加強品管並提高病患留存率。

為醫療保健提供者和供應商提供切實有效的建議，以增強供應鏈韌性、加快臨床部署、最佳化支付方參與度，並擴大患者在各個護理路徑中的就醫途徑。

領導者應優先考慮切實可行的策略，以克服複雜性並獲得臨床和商業性效益。首先，應實現採購管道多元化，並為關鍵診斷設備和一次性耗材建立雙源採購系統，以降低貿易中斷帶來的風險。其次，應投資臨床培訓項目，以加速玻璃化冷凍療法、微創體外受精通訊協定和先進診斷流程的安全實施，從而改善治療效果和患者滿意度。第三，應擴大遠端醫療和數位化諮詢的覆蓋範圍，以簡化治療前評估，提高患者依從性，並減少增加成本的非臨床接觸點。

一個透明的多方法研究框架，整合了專家訪談、臨床文獻綜述和供應商評估，旨在驗證檢驗並識別策略風險領域。

本研究途徑採用定性和定量相結合的方法，以確保研究結果的嚴謹性和可重複性。主要資料收集包括對醫療機構的臨床負責人、檢查室經理和採購負責人進行結構化訪談，並輔以生殖內分泌學家和衛生經濟學專家組成的專家小組的意見。次要研究包括對同儕審查的臨床文獻、監管指南和技術白皮書進行系統性回顧，以檢驗不同治療方案和檢查室工作流程的臨床療效和安全性。

它簡潔地整合了創新、政策影響和策略要求，為醫療保健提供者和供應商提供了清晰的藍圖，以保護品質並擴大患者的就醫途徑。

生育服務正經歷著一場意義深遠的變革時期，其特點是臨床創新、患者期望的不斷變化以及營運複雜性的日益增加。冷凍保存技術的進步、體外受精通訊協定的改進以及數位化醫療模式的整合，正在重塑診所和診斷檢查室的價值創造方式。同時，外部壓力，特別是貿易相關政策的變化，凸顯了籌資策略和供應鏈韌性的重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：依治療方法分類的不孕症治療服務市場

  • 冷凍保存
    • 慢速冷凍
    • 玻璃化冷凍
  • 體外受精
    • 常規體外受精
    • 微試管嬰兒
  • 胞漿內單一精子注射（ICSI）
  • 子宮內人工授精
  • 誘導排卵

第9章：以不孕症類型分類的不孕症治療服務市場

  • 綜合因素
  • 女性因素
  • 男性因素
  • 原因不明

第10章：按支付方式分類的不孕症治療服務市場

  • 保險範圍
    • 公共保險
    • 私人保險
  • 自費
    • 雇主承擔的費用
    • 自有資金

第11章：依治療階段分類的不孕症治療服務市場

  • 新鮮胚胎移植
  • 冷凍胚胎移植
    • 選擇性冷凍胚胎移植
    • 冷凍胚胎移植合併藥物治療

第12章：不孕症治療服務市場：依年齡層別分類

  • 40歲以上
  • 35至40歲
  • 35歲以下

第13章：不孕症治療服務市場：依最終用戶分類

  • 診斷檢查室
  • 不孕症治療診所
  • 醫院
  • 外科中心

第14章：不孕症治療服務市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：不孕症治療服務市場：依群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 不孕症治療服務市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國不孕症治療服務市場

第18章：中國不孕症治療服務市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Bayer AG
  • Boston IVF, LLC
  • CCRM Ltd.
  • Cook Group
  • Eugin Group Holding SL
  • Extend Fertility, LLC
  • Fujifilm Holdings Corporation
  • Gedeon Richter Plc
  • Inception Fertility, LLC
  • IVI SA
  • Kindbody, Inc.
  • Monash IVF Group Limited
  • Progyny, Inc.
  • Shady Grove Fertility, LLC
Product Code: MRR-535C62918B36

The Fertility Services Market was valued at USD 51.44 billion in 2025 and is projected to grow to USD 55.64 billion in 2026, with a CAGR of 8.33%, reaching USD 90.07 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 51.44 billion
Estimated Year [2026] USD 55.64 billion
Forecast Year [2032] USD 90.07 billion
CAGR (%) 8.33%

An authoritative overview of emergent clinical innovations, patient expectations, supply chain pressures, and strategic imperatives reshaping fertility service delivery across care settings

The fertility services landscape sits at the intersection of rapid clinical innovation, shifting demographic patterns, and evolving payer and regulatory dynamics. Clinical practice is expanding beyond traditional in vitro fertilization pathways, with cryopreservation strategies and adjunctive technologies reshaping care delivery. Concurrently, patient expectations around convenience, transparency, and outcomes are prompting clinics and diagnostic laboratories to refine protocols, invest in digital engagement, and adopt evidence-based quality metrics.

These developments are unfolding against a complex backdrop of supply chain vulnerabilities and changing trade policies that influence access to specialized consumables and laboratory equipment. As a result, organizational leaders and clinical directors must balance investments in new clinical capabilities with operational resilience. The following executive summary distills the most consequential shifts, synthesizes segmentation and regional nuances, presents implications for provider and payer stakeholders, and offers pragmatic recommendations to translate insights into measurable operational improvements.

A forward-looking synthesis of clinical innovation, digital transformation, demographic change, and policy dynamics that are collectively reordering the fertility services ecosystem

Technological innovation and service delivery models are driving transformative shifts across every node of the fertility pathway. Advances in cryopreservation techniques, from slow freezing to vitrification, are increasing embryo and gamete viability and enabling clinics to diversify treatment sequencing. Simultaneously, refinements in conventional IVF protocols and the emergence of mini-IVF approaches allow clinicians to tailor stimulation intensity to patient age cohorts and infertility presentations, thereby optimizing safety and outcomes.

Parallel to clinical evolution, digital health and telemedicine are improving pre-treatment counseling, follow-up, and patient adherence, while genomic screening and precision diagnostics are refining embryo selection and male factor assessment. These shifts are altering demand patterns across diagnostic laboratories, fertility clinics, hospitals, and surgical centers, and they are influencing how payers and self-paying patients prioritize care pathways. Moreover, changing patient demographics, including delayed childbearing and evolving family structures, are increasing attention on age-stratified strategies and the relative use of fresh versus frozen embryo transfers.

Finally, regulatory and reimbursement landscapes are prompting providers to rethink pricing transparency, outcomes reporting, and partnership models with suppliers. In combination, these dynamics create both opportunity and complexity: organizations that integrate clinical innovation with operational resilience and patient-centered service models will secure competitive advantage and deliver higher perceived value.

How trade policy shifts and tariff measures enacted in 2025 are reshaping procurement resilience, clinical operations, and patient affordability across fertility care delivery channels

The implementation of tariffs and related trade measures in 2025 has introduced new and varied pressures across procurement, clinical operations, and patient affordability. Restrictions on imported laboratory instrumentation, specialized consumables, and cryogenic storage components have raised the visibility of sourcing risk, prompting many providers and diagnostic laboratories to re-evaluate vendor strategies. As a result, some organizations are accelerating qualification of alternative suppliers, increasing inventory buffers, and exploring localized manufacturing partnerships to insulate critical clinical workflows from supply chain shocks.

These trade-related frictions also influence cost structures in different care settings. Fertility clinics and surgical centers that rely on high-specification incubators, disposables, or imported reagents may encounter tighter margins or the need to adjust pricing models for self-pay patients. Hospitals and larger health systems have scope to centralize purchasing and negotiate volume-based arrangements, while standalone clinics often face more acute exposure. In parallel, payers and government insurance programs are reassessing coverage thresholds and reimbursement terms to account for shifting input costs, which can influence patient decisions between insurance-covered pathways and out-of-pocket funding options such as employer reimbursement or self-funding.

In response, leading organizations are pursuing diversified procurement, bilateral supplier agreements, and programmatic investments in supply-chain visibility. They are also refining clinical protocols to reduce dependence on single-source consumables without compromising outcomes. As policies evolve, providers that actively engage with regulators and payers to articulate the clinical implications of trade measures will be better positioned to mitigate access disruptions and preserve continuity of care.

Deep segmentation-driven insights highlighting how procedure selection, care setting, infertility etiology, payment mechanisms, treatment sequencing, and age cohorts influence clinical pathways and service design

Segment-specific dynamics are central to understanding service demand, clinical adoption, and revenue pathways across the fertility continuum. Procedure-level differentiation is pronounced: cryopreservation strategies vary between slow freezing and vitrification, with vitrification increasingly preferred for its rapid cooling profile and improved survival rates, while conventional IVF and mini-IVF present distinct clinical trade-offs between stimulation intensity and patient tolerance. Intracytoplasmic sperm injection, intrauterine insemination, and ovulation induction continue to play discrete roles in protocol selection, with choice guided by underlying infertility type-whether combined factor, female factor, male factor, or unexplained-and by patient age profile.

End-user context shapes operational design and capital allocation. Diagnostic laboratories focus on assay throughput, quality control, and rapid turnaround for genetic and semen analysis, whereas fertility clinics emphasize patient experience, cycle management, and outcomes tracking; hospitals and surgical centers integrate fertility procedures within broader perioperative and reproductive health services. Payment structures further influence patient pathways: when insurance coverage is available through government or private plans, utilization patterns differ from scenarios in which patients rely on employer reimbursement or self-funding. This interplay affects uptake of elective services such as frozen embryo transfer variants and the sequencing between fresh and frozen embryo strategies.

Age group segmentation remains a defining axis for clinical decision-making. Patients over forty typically follow alternative stimulation and transfer strategies compared with those aged thirty-five to forty or under thirty-five, with age-informed counseling shaping expectations and treatment choice. Across all segments, the most resilient providers apply stratified clinical algorithms, align reimbursement conversations early in the care pathway, and maintain flexible operational capacity to accommodate the variable demand driven by procedure type, end-user setting, infertility etiology, payment source, treatment stage, and patient age.

Regional dynamics and cross-border care considerations that drive differential technology adoption, regulatory compliance, payer interactions, and patient mobility across global fertility markets

Regional dynamics exert a strong influence on access models, pricing frameworks, and the cross-border flow of patients and services. The Americas continue to host diverse delivery models, from privately funded clinic networks to public-sector programs that shape payer negotiations and service bundling. Throughout these markets, regulatory clarity and established reimbursement channels support adoption of advanced laboratory techniques, though pricing sensitivity among self-paying patients drives demand for lower-intensity stimulation protocols and alternative treatment sequencing.

In Europe, the Middle East and Africa, regulatory heterogeneity is pronounced and cultural factors deeply inform care-seeking behavior. Several jurisdictions emphasize stringent laboratory accreditation and donor regulations, which in turn favor established clinic networks and accredited diagnostic laboratories. Concurrently, parts of the region are significant sources of medical travel, drawing patients who seek specialized protocols or more favorable legal frameworks for reproductive services.

Asia-Pacific presents a complex mosaic of rapid technology adoption, varied reimbursement models, and concentrated fertility hubs that attract international patients. Investments in laboratory capacity, a strong supplier base for reproductive technologies, and an expanding private clinic sector are notable features. Across all regions, regional policy measures, local manufacturing capacity, and the degree of payer participation in fertility benefits materially influence providers' strategic decisions related to service mix, pricing, and cross-border collaboration.

Competitive and collaborative company strategies emphasizing product quality, vertical integration, supply-chain resilience, and clinical education as levers of differentiation and market access

Competitive dynamics in the fertility ecosystem favor organizations that combine clinical excellence with operational scale and integrated service offerings. Manufacturers of reproductive technologies and consumables are investing in product quality, regulatory support, and training programs to facilitate clinic adoption of advanced protocols. Diagnostic providers are differentiating through assay precision, rapid result delivery, and integrated reporting that supports embryo selection and male factor assessment. Concurrently, clinic groups and hospital systems are exploring vertical integration strategies that bring laboratory services in-house to enhance quality control and patient retention.

Strategic partnerships and targeted investments are common themes: collaborations between device manufacturers and clinical networks help accelerate adoption of new techniques while reducing training friction. Service providers that embed digital patient engagement platforms and outcomes measurement frameworks secure higher retention and better-informed consent processes. At the same time, distribution and logistics partners that offer cold-chain reliability and responsive replenishment play a critical role in preserving clinical continuity, particularly where supply chain disruptions or tariff-induced constraints raise operational risk. Overall, the most adaptive organizations combine product innovation, clinical education, and supply-chain resilience to sustain competitive advantage.

Practical, high-impact recommendations for providers and suppliers to build supply resilience, accelerate clinical adoption, optimize payer engagement, and expand patient access across care pathways

Leaders should prioritize a set of actionable strategies to navigate complexity and capture clinical and commercial upside. First, diversify procurement channels and formalize dual-sourcing arrangements for critical laboratory equipment and single-use consumables to reduce exposure to trade disruptions. Second, invest in clinical training programs that accelerate safe adoption of vitrification, mini-IVF protocols, and advanced diagnostic workflows, thereby improving outcomes and patient satisfaction. Third, expand telemedicine and digital counseling to streamline pre-treatment assessment, increase patient adherence, and reduce nonclinical touchpoints that add cost.

Further, engage proactively with payers and benefit managers to craft coverage pathways that reflect the value of evidence-based protocols and to explore bundled payment models that align clinical incentives. Strengthen data capture and outcomes reporting to support reimbursement discussions and to enable continuous quality improvement. From an organizational perspective, consider regional partnerships or joint ventures to enter markets with complex regulatory or logistical barriers. Finally, develop patient-centric pricing and financing options-such as staged payment plans, employer reimbursement navigation, and outcome-based agreements-to broaden access and manage affordability concerns while preserving clinical standards.

A transparent, multi-method research framework integrating primary expert interviews, clinical literature review, and supplier assessments to validate insights and identify strategic risk areas

The research approach combined qualitative and quantitative methods to ensure rigorous and reproducible findings. Primary data collection included structured interviews with clinical leaders, laboratory directors, and procurement executives across care settings, complemented by expert panels with reproductive endocrinologists and health economics specialists. Secondary research encompassed a systematic review of peer-reviewed clinical literature, regulatory guidance, and technology white papers to validate clinical efficacy and safety profiles for procedural variations and laboratory workflows.

Analytical triangulation synthesized interview insights, clinical evidence, and supplier assessments to identify consistent patterns and to surface risk areas such as supply-chain exposure and payer sensitivity. The methodology emphasized transparency in data sources and limitations, documenting assumptions underlying segmentation analysis and flagging areas where evolving policy or clinical evidence could alter operational conclusions. Ethical considerations included anonymization of interview data and adherence to professional standards for clinical reporting, ensuring that recommendations are grounded in robust evidence and stakeholder experience.

A concise synthesis of innovation, policy impact, and strategic imperatives offering a clear roadmap for providers and suppliers to safeguard quality and expand patient access

Fertility services are undergoing a period of substantive change characterized by clinical innovation, evolving patient expectations, and greater operational complexity. Advances in cryopreservation, refinements in IVF protocols, and the integration of digital care models are reshaping how clinics and diagnostic laboratories deliver value. At the same time, external pressures-particularly trade-related policy shifts-are elevating the importance of procurement strategy and supply-chain resilience.

Strategic clarity emerges from segmentation-aware planning, regional sensitivity, and proactive payer engagement. Providers and suppliers that implement diversified sourcing, invest in clinician training, and adopt robust outcomes measurement will be better positioned to navigate uncertainty and to capture growth in patient demand. The recommendations summarized here provide a practical roadmap to translate insights into operational actions that preserve quality, improve access, and strengthen the financial sustainability of fertility service delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Fertility Services Market, by Procedure Type

  • 8.1. Cryopreservation
    • 8.1.1. Slow Freezing
    • 8.1.2. Vitrification
  • 8.2. In Vitro Fertilization
    • 8.2.1. Conventional IVF
    • 8.2.2. Mini IVF
  • 8.3. Intracytoplasmic Sperm Injection
  • 8.4. Intrauterine Insemination
  • 8.5. Ovulation Induction

9. Fertility Services Market, by Infertility Type

  • 9.1. Combined Factor
  • 9.2. Female Factor
  • 9.3. Male Factor
  • 9.4. Unexplained

10. Fertility Services Market, by Payment Type

  • 10.1. Insurance Coverage
    • 10.1.1. Government Insurance
    • 10.1.2. Private Insurance
  • 10.2. Out Of Pocket
    • 10.2.1. Employer Reimbursement
    • 10.2.2. Self Funding

11. Fertility Services Market, by Treatment Stage

  • 11.1. Fresh Embryo Transfer
  • 11.2. Frozen Embryo Transfer
    • 11.2.1. Elective Frozen Embryo Transfer
    • 11.2.2. Medicated Frozen Embryo Transfer

12. Fertility Services Market, by Age Group

  • 12.1. Over Forty
  • 12.2. Thirty Five To Forty
  • 12.3. Under Thirty Five

13. Fertility Services Market, by End User

  • 13.1. Diagnostic Laboratories
  • 13.2. Fertility Clinics
  • 13.3. Hospitals
  • 13.4. Surgical Centers

14. Fertility Services Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Fertility Services Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Fertility Services Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Fertility Services Market

18. China Fertility Services Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Bayer AG
  • 19.6. Boston IVF, LLC
  • 19.7. CCRM Ltd.
  • 19.8. Cook Group
  • 19.9. Eugin Group Holding S.L.
  • 19.10. Extend Fertility, LLC
  • 19.11. Fujifilm Holdings Corporation
  • 19.12. Gedeon Richter Plc
  • 19.13. Inception Fertility, LLC
  • 19.14. IVI S.A.
  • 19.15. Kindbody, Inc.
  • 19.16. Monash IVF Group Limited
  • 19.17. Progyny, Inc.
  • 19.18. Shady Grove Fertility, LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL FERTILITY SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FERTILITY SERVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FERTILITY SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FERTILITY SERVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FERTILITY SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL FERTILITY SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES FERTILITY SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA FERTILITY SERVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FERTILITY SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SLOW FREEZING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SLOW FREEZING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SLOW FREEZING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FERTILITY SERVICES MARKET SIZE, BY VITRIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FERTILITY SERVICES MARKET SIZE, BY VITRIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FERTILITY SERVICES MARKET SIZE, BY VITRIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FERTILITY SERVICES MARKET SIZE, BY CONVENTIONAL IVF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FERTILITY SERVICES MARKET SIZE, BY CONVENTIONAL IVF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FERTILITY SERVICES MARKET SIZE, BY CONVENTIONAL IVF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FERTILITY SERVICES MARKET SIZE, BY MINI IVF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FERTILITY SERVICES MARKET SIZE, BY MINI IVF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FERTILITY SERVICES MARKET SIZE, BY MINI IVF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FERTILITY SERVICES MARKET SIZE, BY OVULATION INDUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FERTILITY SERVICES MARKET SIZE, BY OVULATION INDUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FERTILITY SERVICES MARKET SIZE, BY OVULATION INDUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FERTILITY SERVICES MARKET SIZE, BY COMBINED FACTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FERTILITY SERVICES MARKET SIZE, BY COMBINED FACTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FERTILITY SERVICES MARKET SIZE, BY COMBINED FACTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FEMALE FACTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FEMALE FACTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FEMALE FACTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FERTILITY SERVICES MARKET SIZE, BY MALE FACTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FERTILITY SERVICES MARKET SIZE, BY MALE FACTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FERTILITY SERVICES MARKET SIZE, BY MALE FACTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FERTILITY SERVICES MARKET SIZE, BY UNEXPLAINED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FERTILITY SERVICES MARKET SIZE, BY UNEXPLAINED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FERTILITY SERVICES MARKET SIZE, BY UNEXPLAINED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FERTILITY SERVICES MARKET SIZE, BY GOVERNMENT INSURANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FERTILITY SERVICES MARKET SIZE, BY GOVERNMENT INSURANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FERTILITY SERVICES MARKET SIZE, BY GOVERNMENT INSURANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FERTILITY SERVICES MARKET SIZE, BY PRIVATE INSURANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FERTILITY SERVICES MARKET SIZE, BY PRIVATE INSURANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FERTILITY SERVICES MARKET SIZE, BY PRIVATE INSURANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FERTILITY SERVICES MARKET SIZE, BY EMPLOYER REIMBURSEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FERTILITY SERVICES MARKET SIZE, BY EMPLOYER REIMBURSEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FERTILITY SERVICES MARKET SIZE, BY EMPLOYER REIMBURSEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SELF FUNDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SELF FUNDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SELF FUNDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FRESH EMBRYO TRANSFER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FRESH EMBRYO TRANSFER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FRESH EMBRYO TRANSFER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL FERTILITY SERVICES MARKET SIZE, BY ELECTIVE FROZEN EMBRYO TRANSFER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FERTILITY SERVICES MARKET SIZE, BY ELECTIVE FROZEN EMBRYO TRANSFER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FERTILITY SERVICES MARKET SIZE, BY ELECTIVE FROZEN EMBRYO TRANSFER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL FERTILITY SERVICES MARKET SIZE, BY MEDICATED FROZEN EMBRYO TRANSFER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL FERTILITY SERVICES MARKET SIZE, BY MEDICATED FROZEN EMBRYO TRANSFER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL FERTILITY SERVICES MARKET SIZE, BY MEDICATED FROZEN EMBRYO TRANSFER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FERTILITY SERVICES MARKET SIZE, BY OVER FORTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FERTILITY SERVICES MARKET SIZE, BY OVER FORTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FERTILITY SERVICES MARKET SIZE, BY OVER FORTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL FERTILITY SERVICES MARKET SIZE, BY THIRTY FIVE TO FORTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL FERTILITY SERVICES MARKET SIZE, BY THIRTY FIVE TO FORTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL FERTILITY SERVICES MARKET SIZE, BY THIRTY FIVE TO FORTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL FERTILITY SERVICES MARKET SIZE, BY UNDER THIRTY FIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL FERTILITY SERVICES MARKET SIZE, BY UNDER THIRTY FIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL FERTILITY SERVICES MARKET SIZE, BY UNDER THIRTY FIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL FERTILITY SERVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FERTILITY SERVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL FERTILITY SERVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FERTILITY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FERTILITY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL FERTILITY SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL FERTILITY SERVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL FERTILITY SERVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL FERTILITY SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS FERTILITY SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL FERTILITY SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. GCC FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. GCC FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. GCC FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 216. GCC FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 217. GCC FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. GCC FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. GCC FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 220. GCC FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 221. GCC FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 222. GCC FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 223. GCC FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 224. GCC FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. G7 FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. G7 FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. G7 FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 252. G7 FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 253. G7 FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. G7 FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. G7 FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 256. G7 FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 257. G7 FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 258. G7 FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 259. G7 FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 260. G7 FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. NATO FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. NATO FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. NATO FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 264. NATO FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 265. NATO FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. NATO FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. NATO FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 268. NATO FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 269. NATO FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 270. NATO FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 271. NATO FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 272. NATO FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. GLOBAL FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES FERTILITY SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA FERTILITY SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 296. CHINA FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)